Results 271 to 280 of about 939,495 (280)

Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

Cancer Letters, 2013
Kiyoshi Okamoto, Naoko Hata Sugi, Akihiko Tsuruoka   +2 more
exaly  

Gavreto, RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions.

American health & drug benefits
This section provides a brief overview of new cancer drugs approved by the FDA between July 24, 2020, and September 4, 2020.
openaire   +1 more source

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making.

Ca-A Cancer Journal for Clinicians
Lucas Leite Cunha, Ana O Hoff, Rachel Riera   +2 more
exaly  

Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing

Lung Cancer, 2018
Xuefei Zhang
exaly  

DETECTION OF RET FUSIONS IN CANCER

2013
DOEBELE ROBERT, GARCIA MARILEILA VARELLA, LE ANH T, XU LIANGGUO   +3 more
openaire   +1 more source

Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”

Cancers
Filippo de Marinis, Ester del Signore, Antonio Passaro   +2 more
exaly  

FUSION PROTEIN OF DCTN1 PROTEIN WITH RET PROTEIN

2019
HAYASHI KOHEI, ISHIDA KEIJI
openaire   +3 more sources

KIF5B-RET fusion molecules and uses thereof

2016
DOWNING SEAN R, HAWRYLUK MATTHEW J, LIPSON DORON, PARKER ALEXANDER N, STEPHENS PHILIP JAMES   +4 more
openaire   +7 more sources

DETECTION METHOD OF NOVEL RET FUSION

2013
SHINDO NOBUAKI, NISHIMURA KOUICHI, SANO YORIKATA, ASAUMI MAKOTO, YAMANAKA AYA, FUTAMI TAKASHI, KAWASE TATSUYA   +6 more
openaire   +2 more sources

RET GENE FUSIONS AND USES THEREOF

GORNSTEIN ERICA, ERBACH RACHEL, LIU XIN, HUANG RICHARD SHENG POE, KUANG ZHENG, PARIMI VAMSI   +5 more
openaire   +1 more source